Charles River Laboratories
CRL
#2080
Rank
A$13.65 B
Marketcap
A$277.48
Share price
0.15%
Change (1 day)
-6.56%
Change (1 year)
Categories

Revenue for Charles River Laboratories (CRL)

Revenue in 2025 (TTM): A$6.27 Billion

According to Charles River Laboratories 's latest financial reports the company's current revenue (TTM ) is A$6.05 Billion. In 2024 the company made a revenue of A$6.51 Billion an increase over the revenue in the year 2023 that were of A$6.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Charles River Laboratories from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$6.27 B-3.59%
2024 A$6.51 B7.43%
2023 A$6.06 B3.74%
2022 A$5.84 B19.65%
2021 A$4.88 B28.41%
2020 A$3.80 B1.57%
2019 A$3.74 B16.39%
2018 A$3.21 B35.19%
2017 A$2.37 B2%
2016 A$2.33 B24.65%
2015 A$1.87 B18.02%
2014 A$1.58 B21.35%
2013 A$1.30 B20.22%
2012 A$1.08 B-2.47%
2011 A$1.11 B1.1%
2010 A$1.10 B-17.66%
2009 A$1.33 B-29.7%
2008 A$1.90 B35.29%
2007 A$1.40 B4.84%
2006 A$1.34 B-9.85%
2005 A$1.48 B50.27%
2004 A$0.99 B20.03%
2003 A$0.82 B-16.13%
2002 A$0.98 B7.9%
2001 A$0.91 B61.26%
2000 A$0.56 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Repligen
RGEN
A$1.06 B-82.41%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
A$4.41 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$65.84 B 986.93%๐Ÿ‡บ๐Ÿ‡ธ USA